Table of Contents
Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Segment Scope
1.1.2 Regional Scope
1.1.3 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database:
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources & Third-Party Perspectives
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information/Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.7 Market Definitions
1.8 List Of Secondary Sources
Chapter 2 Executive Summary
2.1 Market Snapshot, 2022
2.2 Segment Snapshot
2.3 Competitive Landscape Snapshot
Chapter 3 Veterinary Active Pharmaceutical Ingredients (API) Manufacturing Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Analysis
3.1.2 Ancillary Market Analysis
3.2 Penetration And Growth Prospect Mapping, By Synthesis Type, 2022
3.3 Veterinary Api Manufacturing Market Dynamics
3.3.1 Market Driver Analysis
3.3.1.1 Increasing Prevalence Of Zoonotic Diseases
3.3.1.2 Increasing Animal Population And Pet Ownership
3.3.1.3 Growing Pet Expenditure
3.3.1.4 Rising Number Of Veterinarians And Veterinary Visits
3.3.1.5 Growing Demand For Pet Insurance
3.3.1.6 Strategic Initiatives Undertaken By Market Players
3.3.1.7 Growing Government Initiatives
3.3.2 Market Restraint Analysis
3.3.2.1 Stringent Government Regulations
3.3.2.2 Lack Of Awareness And High Cost Of Animal Care
3.3.3 Market Challenges Analysis
3.3.3.1 Illegal Veterinary Medicines
3.3.3.2 Challenges In Large Molecule Api Synthesis
3.4 Veterinary Active Pharmaceutical Ingredients (Api) Manufacturing Market Analysis Tools: Porters
3.4.1 Bargaining Power Of Suppliers: Low
3.4.2 Bargaining Power Of Buyers: Moderate
3.4.3 Threat Of Substitutes: Moderate
3.4.4 Threat Of New Entrants: Moderate
3.4.5 Competitive Rivalry: High
3.5 Veterinary Active Pharmaceutical Ingredients (Api) Manufacturing Market Analysis Tools: Pest Analysis
3.5.1 Political & Legal Landscape
3.5.2 Economic Landscape
3.5.3 Social Landscape
3.5.4 Technology Landscape
3.6 Regulatory Landscape
3.6.1 North America
3.6.2 Europe
3.6.3 Asia-Pacific
3.6.4 Latin America
3.6.5 MEA
3.7 Pricing Analysis
3.8 Forecast Analysis
3.8.1 Technology & Trends In Api Manufacturing
Chapter 4 Service Type Estimates & Trend Analysis, 2018 – 2030 (USD Million)
4.1 Service Type Movement Analysis, 2018 – 2030 (USD Million)
4.2 Veterinary Active Pharmaceutical Ingredients (API) Manufacturing Market Share Analysis, 2022 & 2030
4.3 In-House
4.3.1 In-House Market Estimates And Forecasts, 2018 – 2030 (USD Million)
4.4 Contract Outsourcing
4.4.1 Contract Outsourcing Market Estimates And Forecasts, 2018 – 2030 (USD Million)
4.4.2 Contract Development
4.4.2.1 Contract Development Market Estimates And Forecasts, 2018 – 2030 (USD Million)
4.4.2.2 Preclinical Development
4.4.2.2.1 Preclinical Development Market Estimates And Forecasts, 2018 – 2030 (USD Million)
4.4.2.3 Others
4.4.2.3.1 Others Market Estimates And Forecasts, 2018 – 2030 (USD Million)
4.4.3 Contract Manufacturing
4.4.3.1 Contract Manufacturing Market Estimates And Forecasts, 2018 – 2030 (USD Million)
4.4.3.2 Api/Bulk Drugs
4.4.3.2.1 Api/Bulk Drugs Market Estimates And Forecasts, 2018 – 2030 (USD Million)
4.4.3.3 Finished Dose Formulations
4.4.3.3.1 Finished Dose Formulations Market Estimates And Forecasts, 2018 – 2030 (USD Million)
Chapter 5 Synthesis Type Estimates & Trend Analysis, 2018 – 2030 (USD Million)
5.1 Synthesis Type Movement Analysis, 2018 – 2030 (USD Million)
5.2 Veterinary Active Pharmaceutical Ingredients (API) Manufacturing Market Share Analysis, 2022 & 2030
5.3 Chemical-Based Api
5.3.1 Chemical-Based Active Pharmaceutical Ingredients Market Estimates And Forecasts, 2018 – 2030 (USD Million)
5.4 Biological Api
5.4.1 Biological Active Pharmaceutical Ingredients Market Estimates And Forecasts, 2018 – 2030 (USD Million)
5.5 Hpapi
5.5.1 Hpapi Market Estimates And Forecasts, 2018 – 2030 (USD Million)
Chapter 6 Therapeutic Category Estimates & Trend Analysis, 2018 – 2030 (USD Million)
6.1 Therapeutic Category Movement Analysis, 2018 – 2030 (USD Million)
6.2 Veterinary Active Pharmaceutical Ingredients (Api) Manufacturing Market Share Analysis, 2022 & 2030
6.3 Antiparasitic
6.3.1 Antiparasitic Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.4 Anti-Infectives
6.4.1 Anti-Infectives Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.5 Nsaids
6.5.1 Nsaids Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.6 Others
6.6.1 Others Market Estimates And Forecasts, 2018 – 2030 (USD Million)
Chapter 7 Animal Type Estimates & Trend Analysis, 2018 – 2030 (USD Million)
7.1 Animal Type Movement Analysis, 2018 – 2030 (USD Million)
7.2 Veterinary Active Pharmaceutical Ingredients (Api) Manufacturing Market Share Analysis, 2022 & 2030
7.3 Companion Animals
7.3.1 Companion Animals Market Estimates And Forecasts, 2018 – 2030 (USD Million)
7.4 Production/Food Animals
7.4.1 Production/Food Animals Market Estimates And Forecasts, 2018 – 2030 (USD Million)
Chapter 8 Regional Estimates & Trend Analysis, 2018 – 2030 (USD Million)
8.1 Regional Market Snapshot
8.2 Regional Market Share Analysis, 2022 & 2030
8.3 North America
8.3.1 North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.3.2 U.S.
8.3.2.1 U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.3.3 Canada
8.3.3.1 Canada Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.4 Europe
8.4.1 Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.4.2 U.K.
8.4.2.1 U.K. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.4.3 Germany
8.4.3.1 Germany Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.4.4 France
8.4.4.1 France Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.4.5 Italy
8.4.5.1 Italy Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.4.6 Spain
8.4.6.1 Spain Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.5 Asia Pacific
8.5.1 Asia Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.5.2 China
8.5.2.1 China Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.5.3 Japan
8.5.3.1 Japan Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.5.4 India
8.5.4.1 India Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.6 Latam
8.6.1 Latam Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.6.2 Brazil
8.6.2.1 Brazil Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.6.3 Mexico
8.6.3.1 Mexico Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.7 MEA
8.7.1 Mea Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.7.2 South Africa
8.7.2.1 South Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.7.3 Saudi Arabia
8.7.3.1 Saudi Arabia Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, 2018 – 2030 (USD Million)
Chapter 9 Competitive Landscape
9.1 Company Market Position Analysis
9.2 Synergy Analysis: Major Deals & Strategic Alliances
Chapter 10 Veterinary Active Pharmaceutical Ingredients (API) Manufacturing Market – Company Profiles
10.1 Alivira Animal Health Limited
10.1.1 Company Overview
10.1.2 Financial Performance
10.1.3 Product Benchmarking
10.1.4 Strategic Initiatives
10.2 Excel Industries Ltd.
10.2.1 Company Overview
10.2.2 Financial Performance
10.2.3 Product Benchmarking
10.3 Ofichem Group
10.3.1 Company Overview
10.3.2 Product Benchmarking
10.3.3 Strategic Initiatives
10.4 Chempro Pharma Private Limited
10.4.1 Company Overview
10.4.2 Product Benchmarking
10.5 Menadiona
10.5.1 Company Overview
10.5.2 Financial Performance
10.5.3 Product Benchmarking
10.5.4 Strategic Initiatives
10.6 SUANFARMA
10.6.1 Company Overview
10.6.2 Financial Performance
10.6.3 Product Benchmarking
10.6.4 STRATEGIC INITIATIVES
10.7 Vetpharma (Insud Pharma, S.L.U)
10.7.1 Company Overview
10.7.2 Product Benchmarking
10.7.3 Strategic Initiatives
10.8 Siflon Drugs
10.8.1 Company Overview
10.8.2 Product Benchmarking
10.9 Qilu Pharmaceuticals Co. Ltd.
10.9.1 Company Overview
10.9.2 Financial Performance
10.9.3 Product Benchmarking
10.10 FIS – Fabbrica Italiana Sintetici S.p.A.
10.10.1 Company Overview
10.10.2 Product Benchmarking
10.10.3 Strategic Initiatives
